Onoyama, Takumi <br/><br/>
Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review.  [electronic resource] 

 -  World journal of gastroenterology  Jan 2020 
 - 353-365 p.  digital 
<br/><br/> Publication Type: Journal Article; Systematic Review 
<br/><br/><label>ISSN: </label>2219-2840 
<br/><br/><label>Standard No.: </label>10.3748/wjg.v26.i3.353  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--chemically induced<br/>Chemical and Drug Induced Liver Injury--etiology<br/>Cholangitis, Sclerosing--chemically induced<br/>Female<br/>Humans<br/>Lung Neoplasms--chemically induced<br/>Male<br/>Middle Aged<br/>Nivolumab--adverse effects<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors